Axiogenesis iPSC - iPSC (ID:70001)

HMS LINCS ID: 70001
Name: Axiogenesis iPSC
Alternative Names: iPSCs derived from human dermal fibroblasts by Ncardia, previously Axiogenesis
LINCS ID:
Alternative ID:
Parent Primary Cell:
Citation Information for Mutations:
Molecular Features:
Passaging Method:
Passage Last Karyotyping:
Recommended Culture Conditions: Complete culture medium recipe:
450mL IMDM (PAN,P04-20150)
500μL Insulin (Insulin solution human, I9278, Sigma)
50mL Fetal calf serum (heat inactivated)
Thioglycerol (400 μM)BMCC serum free culture medium recipe:
500ml IMDM (PAN,P04-20150)
500μl Insulin (Insulin solution human, I9278, Sigma)
5ml CD-Lipids (CD Lipids concentrate, 11905-031, Gibco)
500μl Trace Elements A ( 25-021-CI, Cellgro)
500μl Trace Elements B ( 99-175-CI, Cellgro)
500μl Trace Elements C (99-176-CI, Cellgro)
250μl Vitamin C ( 100mg/ml Stock)
Thioglycerol (400 μM)
Molecular Features:
Related Projects:
Cell Markers:
Genetic Modification(s):
Production Details: generated using the Yamanaka protocol (inducing factors Oct3/4, Sox2, Klf4, c-Myc)
Comments:
Date Publicly Available: 2017-09-29
Most Recent Update: 2018-03-20

Batch Information for HMSL70001-1:

HMS LINCS Batch ID: 70001-1
Provider: Ncardia, previously Axiogenesis
Provider Catalog ID:
Provider Batch ID:
Source Information:
Date Received:
HMS QC Outcome:
Culture Conditions:
Passage Number:
Transient Modification(s):
Comments:
Date Publicly Available: 2017-09-29
Most Recent Update: 2018-03-20